#GLENMARK Setting Up for a Pre-Breakout!
💊 Stock Alert: #GLENMARK Setting Up for a Pre-Breakout! 💊
📈 Ready for Another Run: After a previous breakout attempt was halted by market volatility, #GLENMARK is now showing renewed strength, rebounding off support as the pharma sector gains momentum. This time, the stock is forming a Darvas Box—a strong indicator of continued bullish momentum. With these signals aligning, #GLENMARK is set for another bullish run, making it a prime candidate for a swing trade. 🔥
💡 Don’t miss this chance to position early for a potential breakout in the pharma sector! 👀
Target: 1950-2000
Stop Loss: 1695
Trade Risk Free Exit (20-30%): 1830
R/R Ratio: 2-3
📢 Disclaimer: This post is for educational purposes only. Always do your own research before making any investment decisions. 💼
#StockMarket #PharmaStocks #DarvasBox #PreBreakout #SwingTrade #InvestSmart
📈 Ready for Another Run: After a previous breakout attempt was halted by market volatility, #GLENMARK is now showing renewed strength, rebounding off support as the pharma sector gains momentum. This time, the stock is forming a Darvas Box—a strong indicator of continued bullish momentum. With these signals aligning, #GLENMARK is set for another bullish run, making it a prime candidate for a swing trade. 🔥
💡 Don’t miss this chance to position early for a potential breakout in the pharma sector! 👀
Target: 1950-2000
Stop Loss: 1695
Trade Risk Free Exit (20-30%): 1830
R/R Ratio: 2-3
📢 Disclaimer: This post is for educational purposes only. Always do your own research before making any investment decisions. 💼
#StockMarket #PharmaStocks #DarvasBox #PreBreakout #SwingTrade #InvestSmart
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.